Equity Overview
Price & Market Data
Price: $13.60
Daily Change: -$0.295 / 2.17%
Range: $13.50 - $13.81
Market Cap: $346,663,296
Volume: 1,203
Performance Metrics
1 Week: 1.38%
1 Month: -0.50%
3 Months: 29.67%
6 Months: 30.40%
1 Year: 103.2%
YTD: 10.37%
Company Details
Employees: 16
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference-based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy. Benitec Biopharma Inc. was incorporated in 1995 and is headquartered in Hayward, California.